Literature DB >> 10750466

PSA screening: the bottom line.

M M Elhilali1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10750466      PMCID: PMC1231272     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.

Authors:  M Greiver; N Rosen
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  The European Screening Study for Prostate Cancer.

Authors:  F H Schröder
Journal:  Can J Oncol       Date:  1994-11

3.  Results of radical prostatectomy in men with clinically localized prostate cancer.

Authors:  G S Gerber; R A Thisted; P T Scardino; H G Frohmuller; F H Schroeder; D F Paulson; A W Middleton; D B Rukstalis; J A Smith; P F Schellhammer; M Ohori; G W Chodak
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

4.  Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

Authors:  O Dillioglugil; B D Leibman; M W Kattan; C Seale-Hawkins; T M Wheeler; P T Scardino
Journal:  Urology       Date:  1997-07       Impact factor: 2.649

5.  Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model.

Authors:  W J Catalona; A W Partin; J A Finlay; D W Chan; H G Rittenhouse; R L Wolfert; D L Woodrum
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

6.  The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.

Authors:  C R Smart
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

7.  The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Authors:  R J Babaian; C Mettlin; R Kane; G P Murphy; F Lee; J R Drago; A Chesley
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

8.  Population-based study of long-term survival in patients with clinically localised prostate cancer.

Authors:  G L Lu-Yao; S L Yao
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

9.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

Authors:  P C Walsh; A W Partin; J I Epstein
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

10.  Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.

Authors:  J K Gohagan; P C Prorok; B S Kramer; J E Cornett
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more
  1 in total

1.  PSA screening and prostate cancer mortality.

Authors:  Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.